Clinical Trials Browser

Phase EARLY_PHASE1 × Denosumab × Clear all

NCT03629717 2024-10-16

RANKL Inhibition and Breast Tissue Biomarkers

Phase EARLY_PHASE1 Completed

Breast Neoplasms

NCT03382574 2022-06-14

Pilot Study of Denosumab in BRCA1/2 Mutation Carriers Scheduled for Risk-Reducing Salpingo-Oophorectomy

Phase EARLY_PHASE1 Terminated

Ovarian Neoplasms

NCT03691311 2021-11-03

D-BIOMARK

Phase EARLY_PHASE1 Unknown

Osteopetrosis, mild autosomal recessive form, Osteopetrosis, Autosomal Recessive 7, Breast Neoplasms

NCT02900469 2020-08-21

Presurgical Trial of Denosumab in Breast Cancer

Phase EARLY_PHASE1 Completed

Breast Neoplasms